Palisade Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,251
Closed -$807K 410
2022
Q3
$807K Buy
39,251
+9,000
+30% +$257K 0.02% 346
2022
Q2
$966K Hold
30,251
0.03% 344
2022
Q1
$1.25M Sell
30,251
-966
-3% -$40.5K 0.03% 333
2021
Q4
$1.39M Buy
31,217
+959
+3% +$46.1K 0.03% 338
2021
Q3
$1.51M Sell
30,258
-14,925
-33% -$777K 0.03% 318
2021
Q2
$2.4M Sell
45,183
-5,937
-12% -$298K 0.05% 283
2021
Q1
$2.34M Hold
51,120
0.05% 275
2020
Q4
$2.45M Buy
51,120
+1,500
+3% +$71.6K 0.06% 272
2020
Q3
$2.21M Sell
49,620
-2,020
-4% -$85.2K 0.07% 274
2020
Q2
$2.01M Buy
51,640
+20,640
+67% +$834K 0.06% 271
2020
Q1
$1.38M Buy
+31,000
New +$1.48M 0.05% 298

Other funds holding ELAT

Palisade Capital Management's ELAT Position: Q4 2022 in Review

Palisade Capital Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 39,251 shares — an estimated $807K sold.

Palisade Capital Management first reported a position in ELAT in Q1 2020 and held it in 11 quarters. The position peaked at $2.45M in Q4 2020. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • Palisade Capital Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • Palisade Capital Management sold 39,251 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $807K.
  • Palisade Capital Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 11 quarters.
  • Palisade Capital Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $2.45M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on Palisade Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.